Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
European Journal of Immunology
|
July 31, 1999
IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice
Q Dong, J Louahed, A Vink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2003
A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer
Roy S Herbst, Lisa A Hammond, David P Carbone, et al.
The Journal of Frailty & Aging
|
February 5, 2022
Nutrition and Physical Activity Clinical Practice Guidelines for Older Adults Living with Frailty
A L Lorbergs, J C Prorok, J Holroyd-Leduc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor
Desirée Hao, Lisa A Hammond, S Gail Eckhardt, et al.
Targeted Oncology
|
December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program
Jill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 16, 1997
Interleukin 9: a candidate gene for asthma
N C Nicolaides, K J Holroyd, S L Ewart, et al.
Frontiers in Genetics
|
August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases
Anup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Assay and Drug Development Technologies
|
December 2, 2017
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data
Jill M Pulley, Rebecca N Jerome, Nicole M Zaleski, et al.
Genomics
|
October 23, 1998
Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region
K J Holroyd, L C Martinati, E Trabetti, et al.
Assay and Drug Development Technologies
|
April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics
Jill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
European Journal of Immunology
|
July 31, 1999
IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice
Q Dong, J Louahed, A Vink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2003
A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer
Roy S Herbst, Lisa A Hammond, David P Carbone, et al.
The Journal of Frailty & Aging
|
February 5, 2022
Nutrition and Physical Activity Clinical Practice Guidelines for Older Adults Living with Frailty
A L Lorbergs, J C Prorok, J Holroyd-Leduc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor
Desirée Hao, Lisa A Hammond, S Gail Eckhardt, et al.
Targeted Oncology
|
December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program
Jill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 16, 1997
Interleukin 9: a candidate gene for asthma
N C Nicolaides, K J Holroyd, S L Ewart, et al.
Frontiers in Genetics
|
August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases
Anup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Assay and Drug Development Technologies
|
December 2, 2017
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data
Jill M Pulley, Rebecca N Jerome, Nicole M Zaleski, et al.
Genomics
|
October 23, 1998
Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region
K J Holroyd, L C Martinati, E Trabetti, et al.
Assay and Drug Development Technologies
|
April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics
Jill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Page
of 9